Amgen (Germany) Top Insiders
AMG Stock | EUR 277.10 0.45 0.16% |
Amgen employs about 25.2 K people. The company is managed by 20 executives with a total tenure of roughly 87 years, averaging almost 4.0 years of service per executive, having 1260.0 employees per reported executive. Examination of Amgen's management performance can provide insight into the company performance.
Willem Hassel Chairman Independent Vice Chairman of the Supervisory Board |
Steve Hanke Chairman Independent Chairman of the Supervisory Board |
Amgen |
Amgen Management Team Effectiveness
The company has return on total asset (ROA) of 0.0997 % which means that it generated a profit of $0.0997 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 1.2647 %, meaning that it generated $1.2647 on every $100 dollars invested by stockholders. Amgen's management efficiency ratios could be used to measure how well Amgen manages its routine affairs as well as how well it operates its assets and liabilities.Amgen Workforce Comparison
Amgen Inc is number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—General industry is presently estimated at about 112,856. Amgen totals roughly 25,200 in number of employees claiming about 22% of equities under Drug Manufacturers—General industry.
The company has Profit Margin (PM) of 0.25 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.38 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.38. Amgen Inc Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Amgen Inc Price Series Summation is a cross summation of Amgen price series and its benchmark/peer.
Amgen Notable Stakeholders
An Amgen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Amgen often face trade-offs trying to please all of them. Amgen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Amgen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Willem Hassel | Independent Vice Chairman of the Supervisory Board | Profile | |
Steve Hanke | Independent Chairman of the Supervisory Board | Profile | |
Heinz Schimmelbusch | Chairman of the Management Board, Chief Executive Officer | Profile | |
Michele Fischer | Vice President IR Contact Officer | Profile | |
Eric Jackson | Member of the Management Board and Presidentident of the AMG Processing Division, COO | Profile | |
Jackson Dunckel | Member of the Management Board, Chief Financial Officer | Profile | |
Linda Louie | VP Officer | Profile | |
Robert Bradway | CEO Chairman | Profile | |
Peter Griffith | Ex CFO | Profile | |
Murdo Gordon | Ex Operations | Profile | |
Dagmar Bottenbruch | Independent Member of the Supervisory Board | Profile | |
Donatella Ceccarelli | Independent Member of the Supervisory Board | Profile | |
Nancy Grygiel | Sr Officer | Profile | |
Frank Lohner | Independent Member of the Supervisory Board | Profile | |
Herbert Depp | Independent Member of the Supervisory Board | Profile | |
Esteban Santos | Ex Operations | Profile | |
Jonathan Graham | Gen VP | Profile | |
Mike Zahigian | VP Officer | Profile | |
David MD | Ex RD | Profile | |
Arvind Sood | VP Relations | Profile |
About Amgen Management Performance
The success or failure of an entity such as Amgen Inc often depends on how effective the management is. Amgen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Amgen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Amgen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. AMGEN INC operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 24300 people.
Amgen Workforce Analysis
Traditionally, organizations such as Amgen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Amgen within its industry.Amgen Manpower Efficiency
Return on Amgen Manpower
Revenue Per Employee | 1M | |
Revenue Per Executive | 1.3B | |
Net Income Per Employee | 260K | |
Net Income Per Executive | 327.6M |
Complementary Tools for Amgen Stock analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Transaction History View history of all your transactions and understand their impact on performance |